Literature DB >> 1901776

Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals.

A Vyakarnam1, P Matear, A Meager, G Kelly, B Stanley, I Weller, P Beverley.   

Abstract

In vitro studies shows that recombinant tumour necrosis factor (TNF) alpha and beta, and interferon-gamma (IFN-gamma) can enhance HIV replication, and peripheral blood mononuclear cells (PBMC) infected with HIV in vitro secrete high levels of the same cytokines. As T cells secrete all three mediators, the capacity of T cell activation signals to trigger cytokine production in PBMC from HIV-infected individuals was investigated as such patients may be immunocompromised. We demonstrate that asymptomatic seropositives in CDC group II/III as well as patients who have progressed to CDC group IV of the disease proliferate efficiently to anti-CD3 antibody, recombinant interleukin-2 (rIL-2), phytohaemagglutinin (PHA), PHA plus phorbol 12,13 dibutyrate (PMA) but secrete significantly (P less than 0.05) higher amounts of TNF-alpha, TNF-beta and IFN-gamma compared with controls in response to the same stimulants. We also show a difference between group II/III and group IV patients with the latter secreting more TNF-alpha and IFN-gamma. The kinetics of TNF-alpha and -beta, and IFN-gamma production was stimulus dependent with overall levels varying in time for each stimulus. Furthermore, the kinetics of the response to all three stimulants were altered in seropositives; CDC group II/III and group IV patients secreted higher levels of cytokines over several time points compared to controls. The altered production of these mediators by HIV-infected patients may contribute to disease progression and to the pathogenesis of AIDS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901776      PMCID: PMC1535370          DOI: 10.1111/j.1365-2249.1991.tb08132.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.

Authors:  S E Tong-Starkesen; P A Luciw; B M Peterlin
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

2.  Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent.

Authors:  S R Carding; J West; A Woods; K Bottomly
Journal:  Eur J Immunol       Date:  1989-02       Impact factor: 5.532

3.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

4.  Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.

Authors:  H W Murray; B Y Rubin; H Masur; R B Roberts
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

5.  HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.

Authors:  B Hofmann; K D Jakobsen; N Odum; E Dickmeiss; P Platz; L P Ryder; C Pedersen; L Mathiesen; I B Bygbjerg; V Faber
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

6.  Enhancement of human immunodeficiency virus production by natural lymphotoxin.

Authors:  T Matsuyama; Y Hamamoto; S Kobayashi; M Kurimoto; J Minowada; N Kobayashi; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

Review 7.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09

8.  Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

Authors:  T Kasahara; J J Hooks; S F Dougherty; J J Oppenheim
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

10.  Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication.

Authors:  A Vyakarnam; J McKeating; A Meager; P C Beverley
Journal:  AIDS       Date:  1990-01       Impact factor: 4.177

View more
  20 in total

1.  Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

Authors:  V Fiorelli; R Gendelman; F Samaniego; P D Markham; B Ensoli
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 2.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment.

Authors:  Michaël Imbeault; Michel Ouellet; Katia Giguère; Jonathan Bertin; Dave Bélanger; Geneviève Martin; Michel J Tremblay
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

4.  Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production.

Authors:  J A Mikovits; H A Young; P Vertino; J P Issa; P M Pitha; S Turcoski-Corrales; D D Taub; C L Petrow; S B Baylin; F W Ruscetti
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Authors:  F Samaniego; P D Markham; R Gendelman; Y Watanabe; V Kao; K Kowalski; J A Sonnabend; A Pintus; R C Gallo; B Ensoli
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

6.  Increased CD11/CD18 expression on the peripheral blood leucocytes of patients with HIV disease: relationship to disease severity.

Authors:  S Palmer; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients.

Authors:  F Diaz-Mitoma; A Kumar; S Karimi; M Kryworuchko; M P Daftarian; W D Creery; L G Filion; W Cameron
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

8.  Down-regulation of CXCR-4 and CCR-5 expression by interferon-gamma is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes.

Authors:  D Creery; W Weiss; W T Lim; Z Aziz; J B Angel; A Kumar
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent.

Authors:  G Lisignoli; M C Monaco; A Degrassi; S Toneguzzi; E Ricchi; P Costigliola; A Facchini
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

Review 10.  HIV associated thrombotic microangiopathy.

Authors:  S Ahmed; R K Siddiqui; A K Siddiqui; S A Zaidi; J Cervia
Journal:  Postgrad Med J       Date:  2002-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.